Genprex Making Progress on Branding for its Lead Cancer Therapy, Oncoprex

Genprex Inc (NASDAQ:GNPX) Chairman and CEO Rodney Varner tells Proactive Investors the biotech has initiated the first phase of branding for its lead drug candidate and has completed the creation and submission of non-proprietary drug name selections to the USAN Council.